Company: IXHL
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110299
Chunk: 48

Company: Incannex Healthcare Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 48
---
 ended  September 30, 

    2025
$  
    2024
$ 

    (in thousands) 
  
    Research and development 
     -  
     - 
  
    General and administrative 
     2,626  
     459 
  
    Total stock-based compensation expense 
     2,626  
     459 

14

Note 10 – Stock-based payments  (continued)

Restricted Stock and Restricted Stock Units

A summary of the changes in the Company’s restricted stock unit
and restricted stock activity for the period ended September 30, 2025, are as follows:

    Numbers of  Shares  
    Weighted  Average Grant  Date Fair Value  $ 
  
    Unvested and Outstanding as of June 30, 2025 
     40,767,047  
     0.23 
  
    Granted 
     100,476  
     0.23 
  
    Vested 
     -  
     - 
  
    Forfeited 
     -  
     - 
  
    Unvested and Outstanding as of September 30, 2025 
     40,867,523  
     0.23 

Stock options

A summary of the changes in the Company’s stock options activity
for the three months ended September 30, 2025, are as follows:

     Number of Shares   Weighted Average Exercise Price ($)   Weighted Average Remaining Contractual Term  (Years)   Aggregate Intrinsic Value  (in thousands) ($)   Outstanding as of June 30, 2025   227,508    27.22    1.46          -   Granted   -    -    -    -   Exercised   -    -    -    -   Cancelled or forfeited   (109,335)   40.16    0.08    -   Outstanding as of September 30, 2025   118,173    15.25    1.78    -   Unvested as of September 30, 2025   -    -    -    -  

The aggregate intrinsic value